Browsing by Author McDonald, David

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2006Chronic gingivitis in a new BTK mutationDao-Ung, L; Liu, Anthony; Nanan, Ralph; McDonald, David; Nepean Clinical School: Medicine; Northern Clinical School: Medicine; Nepean Clinical School: Paediatrics & Child HealthChronic gingivitis in a new BTK mutation, European Journal of Haematology, vol.76,(N/A),2006,pp 171-175
2013The effect of degree of polymerization on intra- and interchain micellization of a tail-type cationic polysoapFitzgerald, Paul; McDonald, David; Warr, Gregory; Chemistry; Chemistry; ChemistryThe effect of degree of polymerization on intra- and interchain micellization of a tail-type cationic polysoap, Soft Matter, vol.9, 9, 2013,pp 2711-2716
2005External quality assurance of DNA testing for thrombophilia mutations.Favaloro, Emmanuel; Hertzberg, Mark; McDonald, David; Neville, Suzanne; Dentistry Faculty; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); ChemistryExternal quality assurance of DNA testing for thrombophilia mutations., American Journal of Clinical Pathology, vol.123,(2),2005,pp 189-193
2002HFE Mutations, Hepatic Iron, and Fibrosis: Ethnic-Specification Association of NASH with C282Y but not with Fibrotic SeverityFarrell, Geoffrey; George, Jacob; Liddle, Christopher; Lin, Rita; Samarasinghe, Dev; Weltman, Martin; Abeygunasekera, Shehan; Chitturi, Shivakumar; McDonald, David; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Nepean Clinical School: MedicineHFE Mutations, Hepatic Iron, and Fibrosis: Ethnic-Specification Association of NASH with C282Y but not with Fibrotic Severity, Hepatology, vol.36, 1,pp 142-149
2013Pharmacologically antagonizing the CXCR4-CXCL12 chemokine pathway with AMD3100 inhibits sunlight-induced skin cancerBeaugie, Clare; Byrne, Scott; Halliday, Gary; Marsh-Wakefield, Felix; McDonald, David; Sarchio, Seri; Scolyer, Richard; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Chemistry; School of Medical Sciences: Bosch Institute; Central Clinical School: PathologyPharmacologically antagonizing the CXCR4-CXCL12 chemokine pathway with AMD3100 inhibits sunlight-induced skin cancer, The Journal of Investigative Dermatology, vol.134, 4, 2013,pp 1091-1100
2014Synthesis and immunological evaluation of self-adjuvanting MUC1-macrophage activating lipopeptide 2 conjugate vaccine candidatesByrne, Scott; Corcilius, Leo; McDonald, David; Payne, Richard; Wilkinson, Brendan Luke; Thaysen-Andersen, Morten; Central Clinical School: Medicine; Chemistry; Chemistry; Chemistry; ChemistrySynthesis and immunological evaluation of self-adjuvanting MUC1-macrophage activating lipopeptide 2 conjugate vaccine candidates, Chemical Communications, vol.50, 71, 2014,pp 10273-10276
2015Synthetic self-adjuvanting glycopeptide cancer vaccinesByrne, Scott; McDonald, David; Payne, Richard; Central Clinical School: Medicine; Chemistry; ChemistrySynthetic self-adjuvanting glycopeptide cancer vaccines, Frontiers in Chemistry, vol.3, 60, 2015,pp 1-8